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Abstract Aromatic amines are an important class of harmful
components of cigarette smoke. Nevertheless, only few of
them have been reported to occur in urine, which raises
questions on the fate of these compounds in the human body.
Here we report on the results of a new analytical method, in
situ derivatization solid phase microextraction (SPME) multi-
dimensional gas chromatography mass spectrometry
(GCxGC-qMS), that allows for a comprehensive fingerprint
analysis of the substance class in complex matrices. Due to the
high polarity of amino compounds, the complex urine matrix
and prevalence of conjugated anilines, pretreatment steps such
as acidic hydrolysis, liquid–liquid extraction (LLE), and de-
rivatization of amines to their corresponding aromatic iodine
compounds are necessary. Prior to detection, the derivatives
were enriched by headspace SPME with the extraction effi-
ciency of the SPME fiber ranging between 65 % and 85 %.
The measurements were carried out in full scan mode with
conservatively estimated limits of detection (LOD) in the
range of several ng/L and relative standard deviation (RSD)
less than 20 %. More than 150 aromatic amines have been
identified in the urine of a smoking person, including
alkylated and halogenated amines as well as substituted naph-
thylamines. Also in the urine of a non-smoker, a number of
aromatic amines have been identified, which suggests that the
detection of biomarkers in urine samples using a more com-
prehensive analysis as detailed in this report may be essential
to complement the approach of the use of classic biomarkers.
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Introduction
Aromatic amines are highly polar organic compounds that are
used or produced in various fields such as drugs, pesticides,
dyes, tobacco smoke, and intermediates for the manufacturing
of other chemicals [1, 2]. Aromatic amines in tobacco smoke
are suggested to be important causing agents for the develop-
ment of bladder cancer in humans [3]. In early studies, human
bladder cancer was frequently associated with occupational
exposure to carcinogenic aromatic amines such as 4-
aminobiphenyl, 2-napthylamine, 2-methylaniline, and 4,4′-
diaminobiphenyl as well as to some polycyclic aromatic hy-
drocarbons (PAHs), and since it has been known that these
chemicals are carcinogenic to humans, their exposure was
highly reduced [2, 4]. However, in the 1950s the composition
of tobacco and cigarette design changed, resulting in high
concentrations of bladder carcinogens such as 2-
naphthylamine to occur in cigarette smoke, and hence an
increased risk of smoking-related bladder cancer [5, 6]. The
International Agency for Research on Cancer (IARC) so far
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classified six aromatic amines as carcinogenic (4-
aminobiphenyl, 2-naphthylamine, and 4,4′-diaminobiphenyl)
or probably carcinogenic [4-chloro-2-methylaniline, 2-
methylaniline, 4,4′-methylene bis (2-chloraniline)] to humans
[7]. They suggested tobacco smoking to be a major cause of
transitional-cell carcinoma (TCC), the most common type
of bladder cancer, where the risk increases with the duration
of smoking and the number of cigarettes smoked [4, 8, 9]. A
cigarette is known to contain up to 600 ingredients and,
when burned, it produces more than 4000 chemicals, of
which some are known to be carcinogenic. Among these,
some aromatic amines are found to be present both in the
main stream and in the side stream smoke [3, 10]. During the
smoking process, aromatic amines are carried into the
bloodstream where they are filtered out of the blood by the
kidneys and end up in the urine. When the urine is stored in
the bladder, aromatic amines get in contact with the cells
that line the bladder where they react and may form high-
grade cancer cells [4]. There is still limited information
about the amount and/or specific aromatic amines that can
cause bladder cancer in humans. There is evidence, though,
that more anilines have to be considered as several amines
were mutagenic in toxicologic testing or caused cancer in
testing animals [11], but the results are difficult to extrapo-
late to humans. In the past few years, several analytical
methods have been published on the analysis of aromatic
amines in human urine [3, 12–14]. However, the studies
were somehow limited to analysis with conventional gas
chromatography, where many isomeric compounds may not
be separated due to their similar retention times and, as a
result, a rather small number of aromatic amines are detect-
ed in urine. To our knowledge, no results have yet been
reported where analysis of aromatic amines in urine was
made by comprehensive two-dimensional chromatography.
The method described here offers a combination of very
sensitive and precise analytical techniques that do not only
isolate and extract the analytes from the matrix but also
decrease their polarity and introduce iodine to the aromatic
ring for the analytes to be detected selectively. Furthermore
multi-dimensional gas chromatography mass spectrometry
(GCxGC-qMS) in combinat ion with sol id phase
microextraction (SPME) was applied to enrich, separate,
and make it possible to distinguish isomers of several aro-
matic amines of the same molecular mass. In addition to the
method development, ionic liquid columns (ILC) were test-
ed to validate if their use could possibly offer better selec-
tivity for iodinated derivatives. The columns covered polar,
highly polar, and extremely polar stationary phases.
This study demonstrates exemplarily patterns of aro-
matic amines found in urine of a smoker and non-
smoker due to their potent carcinogenic effect that can




Aromatic amines and reference substances with a purity of
>97 % were purchased from Sigma-Aldrich, Steinheim, Ger-
many and Alfa-Aesar, Karlsruhe, Germany. The reagents used
for hydrolysis and derivatization, namely concentrated hydro-
chloric acid (37%), hydriodic acid (55%, unstabilized, A.C.S.),
sodium nitrite (≥97 %), sodium sulphite (≥98 %),
alizarinsulfonic acid (98 %), and amidosulfonic acid (99,
3 %) were all products of Sigma-Aldrich. Sodium hydroxide
(99 %) was from VWR, Darmstadt, Germany, and sodium
acetate (≥99 %) from Applichem, Darmstadt, Germany. Ana-
lytical grade methanol was purchased fromKMFLaborchemie,
Lohmar, Germany, and the ultra-filtered water used was a
product of PureLab Ultra (ELGA LabWater, Celle, Germany).
Stock solution and standard preparation
Stock solutions were prepared by weighing approximately
10 mg of each pure substance in a 10-mL volumetric flask
and diluting it with analytical grade methanol to make a final
concentration of 1 g/L. From the stock solution, standard
solutions with concentrations from 1 ng/L to 500 ng/L were
prepared in an aqueous medium by dilution using Hamilton
syringes. The stock solution, as long as it was not used, was
kept cool in a refrigerator at 4 °C for at most 1 mo. The diluted
standards were freshly prepared from the stock solution for
every analysis.
Urine sample preparation
Urine samples were collected randomly from smoking and
nonsmoking donors in 50-mL polypropylene tubes. Into
20 mL urine sample, 10 mL concentrated hydrochloric acid
(37 %) was added and the mixture was heated in properly
closed vials for 12 h at 110 °C to cleave aromatic amine
adducts. After cooling to room temperature, the samples were
made alkaline by adding 20 mL of a 10-M sodium hydroxide
solution so that the amines will be present in their non-charged
form. During this process, a black precipitate forms that could
disturb extraction and, therefore, the samples had to be filtered
using a filter paper. The filtered samples were extracted three
times, with 5-mL diethylether while shaken manually for
about 1 min and then left to stand for another 1 min to allow
the separation of aqueous and organic layers. The aqueous
phase was discarded and the organic phase was kept and
washed once with 2 mL of 0.1M sodium hydroxide solution.
The amines in the organic phase were extracted back into the
aqueous phase with 5 mL water acidified with 100 μL con-
centrated hydrochloric acid (37 %). The remaining
diethylether in the aqueous samples was gently evaporated
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in a nitrogen stream for 5 min. Urine samples of both smoker
and non-smoker were prepared in duplicate.
Derivatization
To decrease the polarity of the extracted amines as well as
introducing iodine in the aromatic ring, the samples were
derivatized through diazotization and iodination in a one-pot
reaction, as partly described by Schmidt et al. [15]. Into each
5 mL extracted sample, 100 μL hydriodic acid (55 %) and
200 μL sodium nitrite (50 g/L) were added and the sample
was shaken for 20 min. During the reaction, the aromatic
amines are diazotized followed by a subsequent substitution
by iodine at the aromatic ring, which results in aromatic iodine
compounds. To destroy the surplus of nitrite, 0.5 mL of
amidosulfonic acid (50 g/L) was added. The sample was
shaken for another 45 min and then heated in a water bath at
95 °C for 5 min to convert the unreacted diazonium ions to
phenols and also to decompose excess amidosulfonic acid.
After cooling to room temperature, 125 μL saturated sodium
sulfite was added to reduce the iodine residue. This is dem-
onstrated by immediate discoloration of an initially brownish
solution. Finally, a 100 μL of 1 alizarinsulfonic acid was
added to the sample followed by 0.5 mL of saturated sodium
acetate to adjust the pH of the sample to pH 5.
SPME
Headspace SPME was used to enrich the iodinated deriv-
atives before measuring by GCxGC-qMS. Prior to extrac-
tion, the headspace vial containing the sample was pre-
incubated for 10 s at the incubation temperature of 60 °C,
while agitating at the speed of 500 rpm. The SPME fiber
was then auto-injected into the headspace vial to extract the
solution in the headspace for 25 min, followed by
desorbing the extracted analytes into the GC-injection port
for 5 min. After every extraction, the SPME fiber was
conditioned in the needle heater for 20 min. For the anal-
yses of authentic standards and urine samples, the same
extraction conditions with the SPME fiber were used and
the solutions were extracted and measured once. To deter-
mine the extraction efficiency of the SPME fiber, depletion
SPME experiments were done by analyzing four reference
substances, namely iodobenzene, methyl-iodobenzene,
chloro-iodobenzene and pentafluoro-iodobenzene. These
substances are the derivatives of very common aromatic
amines except for pentafluoro-iodobenzene, which was
used as an internal standard. A 5 μg/L mixture of these
four compounds was prepared in a 10-mL volumetric flask
and made up to the mark with water; 2 mL of the solution
was transferred into a 20-mL headspace vial and diluted
with 8 mL water to make a final concentration of 1 μg/L, in
triplicate. Each solution was extracted with the SPME fiber
and measured five times consecutively.
Instrumentation
All analyses were performed by a Shimadzu GC system
consisting of a GC-2010 and GCMS QP2010 Plus (Shimadzu
GmbH, Duisburg, Germany) with a built-in loop-type modu-
lator from Zoex Corporation (Houston (Texas), USA). The
system is coupled with a Shimadzu AOC-5000 liquid, head-
space, and SPME GC injection system, which has a control
panel for mobilizing samples and injectors. The SPME fiber
used for sample enrichment was 65 μm PDMS/DVB (Sigma-
Aldrich, Schnelldorf, Germany) with a SPME liner of
0.75 mm×5.0 mm×95 mm made for Shimadzu GCs. The
GC columns used were, for the first dimension, a DB-5, 30 m,
0.25 mm i.d., 0.25 μm film from Agilent Technologies,
Waldbronn, Germany and for the second dimension, a BPX-
50, 2.7 m, 0.15 mm i.d., 0.15 μm film from SGE Analytical
Science, Griesheim, Germany. Ionic liquid columns namely
SLB IL-59 (polar), SLB IL-61 (polar), SLB IL-76 (highly
polar), SLB IL-82 (highly polar), and SLB IL-100 (extremely
polar) were supplied by Sigma-Aldrich, Taufkirchen, Germany
with 2.7 m, 0.1 mm i.d. and 0.08 μm film. The second column
was coiled around the Zoex loop-type modulator allowing 1
meter after cryo-focusing to the detector. The modulation time
was set at 6 s. Helium was used as carrier gas and the nitrogen
cooled by liquid nitrogen for cryogenic effect. In the case where
GC/MS was used, the cold jet was set off, hence no modulation
and cryogenic effect was needed. The column temperature
gradient was set initially at 60 °C and held for 3 min, then
increased to 230 °C at 5 °C/min and held for another 3 min. At
this start temperature (60 °C) the column head pressure was 97
kPa. The column flowwas set at 1mL/minwith a linear velocity
of 29 cm/s. The temperature of injection port and MS interface
were set at 250 °C and the ion source temperature at 230 °C. The
instrument was operated in the splitless injection mode with the
detector voltage at 1.2 kVand scan rate of 10,000 u/s in full scan
mode. The scanned mass-to-charge ratios were between m/z 70
and 300 for authentic standards (scan speed=0.02) and m/z 70–
460 for urine samples (scan speed=0.03). The data was proc-
essed via GCxGC Software, GC Image (Shimadzu GmbH,
Duisburg, Germany).
Safety considerations
Some pure substances of aromatic amines are highly toxic
and/or carcinogenic. Therefore, care should be taken dur-
ing the preparation of stock solutions by strictly using
protection wear such as nose mask, hand gloves, labora-
tory coat, etc. as well as working strictly under the fume
hood. Some symptoms of contact with the substances are
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itching skin, irritation in the nose, and sudden sharp
headaches when inhaled.
Results and discussion
Determination of extraction ratio by depletion SPME
To test the depletion SPME model as described by Zimmer-
mann et al. [16], a 10 mL sample (n=3) containing four
reference substances at a concentration of 1 μg/L was ana-
lyzed. A 65 μm PDMS/DVB fiber was used where each
sample placed in a 20-mL headspace vial was extracted in
the headspace (vial penetration of 22 mm) and analyzed by
GC/MS five times consecutively. The conditions for extrac-
tion with the SPME fiber are as described previously. The
exponential decay of the peak areas for each analyte, in
correlation with the number of extraction, was observed. This
is demonstrated in Fig. 1a where the mean peak areas for each
analyte are plotted against the number of extraction (x). For
methyl-iodobenzene, more than 80 % of the analytes were
extracted after the third extraction time and no more analytes
could be extracted from the solution. Hence, the number of
extractions (x) shown is up to three. The same applies for
pentafluoro-iodobenzene with the number of extraction (x)
shown up to four. To determine the SPME fiber extraction
efficiency, the following equation was used:
nf ;x ¼ ns;oE 1‐Eð Þx‐1 ð1Þ
where nf,x is the extracted amount of analytes, ns,o the initial
amount of analytes in the sample, E the extraction ratio, and x
the number of the consecutive extraction steps. The results can
be compared with the fitting function f(x) = abxwith a = ns,o E
and b = 1- E. From this equation, the extraction ratio E could
be easily determined from the slope b after linearization:
lognf ;x ¼ log ns;oE
 þ x−1ð Þlog 1‐Eð Þ ð2Þ
Figure 1b shows the log peak areas plotted against the
number of extraction, x.
Fig. 1 Multiple extraction of a
sample containing four iodinated
compounds at a concentration of
1 μg/L using a 65 μm
PDMS/DVB SPME fiber and the
determination of peaks area with
GC/MS. In (a) mean peak area
and in (b) log (peak area) are
plotted against the number of
extraction, x where n=3. Relative
standard deviations (RSD) were
≤7 % for the first two extractions
and ≤20 % for extractions 3 to 5.
The RSDs are not shown here to
increase legibility
Table 1 Calculated extraction ratios, E and fiber sample partition coef-
ficients, Kfs for depletion SPME
Compound R2 Slope [log (1-E)] E (%) Kfs
Pentafluoro-iodobenzene 0.9981 –0.6565 78±6.2 80579
Iodobenzene 0.9991 –0.4657 66±5.8 43727
Methyl-iodobenzene 0.9998 –0.7950 84±7.1 119318
Chloro-iodobenzene 0.9989 –0.5489 72±6.0 57581
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The slopes obtained from the plots and the calculated
extraction ratios of the analytes are shown in Table 1 with
extraction efficiency of the SPME fiber ranging between 65%
and 85 %, with confidence intervals between 5.8 % and 7.1 %
and RSD of 4 %–7 %. The fiber-sample partition coefficient
(Kfs) of each compound was calculated from the extraction
ratios using the equation below:
Kfs ¼ VsE=V f 1‐Eð Þ ð3Þ
where Kfs is the partition coefficient between the fiber coating f
and the aqueous sample s and Vs and Vf are the volumes of the
sample (10 mL) and the fiber coating (0.440 μL), respectively.
Fig. 2 A 100 ng/L standard mixture of 16 derivatized aromatic amines and analysis by GCxGC-qMS for the method development. The analytes are
numbered based on their elution time and are listed in Table 2
Table 2 Names and fragments of the iodinated derivatives analyzed for method development with estimated LODs indicated for aqueous standards
No. Substance Derivatives Fragments of the iodinated
derivatives (m/z)
LODs estimated from
calibration [17] in ng/L
1 Aniline Iodobenzene 204, 77 24.4
2 o-Methylaniline 1-Iodo-2-methylbenzene 218, 91 5.2a
3 p-Methylaniline 1-Iodo-4-methylbenzene 218, 91 5.2a
4 3-Chloro-4-fluoroaniline 3-Chloro-4-fluoro-1-iodobenzene 256, 129 18.8
5 2-Chloroaniline 2-Chloro-1-iodobenzene 238, 111 3.8
6 4-Ethylaniline 4-Ethyl-1-iodobenzene 232, 217,105 11.4
7 2,6-Dimethylaniline 2,6-Dimethyl-1-iodobenzene 232, 105 9.3
8 2,4-Dimethylaniline 2,4-Dimethyl-1-iodobenzene 232, 105 9.3
9 4-Chloro-2-methylaniline 4-Chloro-1-iodo-2-methylbenzene 252, 125 4.3
10 2-Bromoaniline 2-Bromo-1-iodobenzene 282, 155 10.9
11 2,4,6-Trimethylaniline 1-Iodo-2,4,6-trimethylbenzene 246, 119 22.4
12 2-Aminoacetophenone 2-Iodoacetophenone 246, 203, 76 n.a.
13 2,6-Dichloroaniline 2,6-Dichloro-1-iodobenzene 272, 145 6.1
14 3-Chloro-2,6-dimethylaniline 3-Chloro-2,6-dimethyl-1-iodobenzene 266, 139 13.4
15 3-Chloro-4-methoxyaniline 3-Chloro-1-iodo-4-methoxybenzene 268, 141 13.1
16 2-Naphthylamine 2-Iodonaphthalene 254, 127 19.3
n.a.: No calibration performed due to low signal intensity below 100 ng/L.
a Compounds 2 and 3 could not be separated and therefore the sum of both was integrated.
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Due to the good precision and the efficient extraction of the
sample, the PDMS/DVB fiber was retained for further experi-
ments, and hence no other SPME fibers were tested.
Method development for GCxGC using pure substances
A standard solution with 16 aromatic amines at 100 ng/L in
aqueous solution was used to optimize instrument parameters
and to develop a method for the determination of aromatic
amines in urine samples. The standards were derivatized as
described in the Experimental section and analyzed by
GCxGC-qMS. In Fig. 2, a 100 ng/L standard is shown as an
example and Table 2 summarizes the names, the derivative
fragments (m/z), and estimated LODs of the analyzed sub-
stances. All the compounds were eluted and well separated
within 30 min in the first-dimension (1D) and within 6 s in the
second-dimension (2D), except for the methylaniline deriva-
tives (analytes 2 and 3), which could not be separated. Con-
versely, dimethylaniline derivatives (analytes 7 and 8) were
well separated. The mass spectra of all derivatives showed the
typical iodine fragment ion signal with 127m/z, which enables
the analytes to be detected selectively, even in complex sam-
ples such as urine. The method was used further to detect
aromatic amines in urine samples.
Choice of second dimension column
In order to investigate further the separation of isomers in the
second dimension, five ILCwere studied and comparedwith the
standard BPX-50 column. The columns, in the order of increas-
ing polarity were: SLB IL - 59, 61, 76, 82, and 100. In the first
dimension, the same column was kept throughout the experi-
ments (DB-5 column, non-polar). For these experiments, a
standard consisting of a mixture of aromatic amines mentioned
in Table 2, except for 3-chloro-4-methoxyaniline, was used. The
standards were derivatized and enriched by headspace SPME as
described before and analyzed by GCxGC-qMS. To compare
the column combinations, peak distribution of the analytes in 2D
space was plotted for all five ILC as shown in Fig. 3 below.
The analytes were better spread in one of the polar IL
columns, IL 61, and two of the highly polar columns, IL 76
and 82. The results obtained imply that different ionic liquids
interact in a comparable way with the iodinated derivatives
analyzed here as the retention times in the second dimension
are similar. Another possibility could be that as compounds elute
from the first dimension they are already near the elution tem-
perature for the second column and are, therefore, poorly
retained. The results are comparable to the BPX-50 column, a
traditional mid-polar GC column used in the experiments men-
tioned previously in this study (for example Fig. 2). As interest-
ing as the ILC features are, BPX-50 was found to be as well
suited for our analytes of interest and, therefore, was retained for
further analysis.
Aromatic amines in urine samples
Urine samples of a tobacco smoker and a non-smoker were
hydrolyzed, extracted, derivatized, and analyzed by GCxGC-
Fig. 3 Distribution of the 15
derivatized aromatic amines
peaks mentioned in Table 2
(except for 3-chloro-4-
methoxyaniline) on the DB-5/
ILC combinations and analysis by
GCxGC-qMS
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Fig. 4 TIC from m/z 70–460 showing aromatic iodine compounds
proposed to be present in the urine of (a) a person without exposure to
cigarette smoke and (b) a smoking person. The same scale was used on
both chromatograms. The red color indicates the high intensity of the
analyte followed by yellow, green, and blue as the intensity decreases.
The samples were measured by SPME GCxGC-qMS after hydrolysis,
liquid–liquid extraction, and derivatization. Numbers in the figure refer to
compounds listed in Table 2 and shown in Fig. 2. Note that not all of the
shown spots are necessarily caused by aniline derivatives
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Table 3 Tentative list of aromatic amines proposed to be present in the urine of a smoker and a non- smoker based on the fragmentation patterns and the
loss of iodine fragment ion m/z 127





urine of a smoker
Isomers found in
urine of non-smoker
Diaminobenzene 330 203, 76 2 2
C1- Diaminobenzene 344 217, 90 3 2
C2- Diaminobenzene 358 231, 104 3 2
C3- Diaminobenzene 372 357, 245 3 3
C4- Diaminobenzene 386 371, 244 1 1
C1- Triaminobenzene 456 329, 202, 75 3 1
Chlorodiaminobenzene 364 237, 110 2 1
C1- Chlorodiaminobenzene 378 343, 251, 124 2 0
Bromodiaminobenzene 408 281, 154, 75 1 1
Tetrahydronaphthylamine 258 131, 102 10 2
C1- Tetrahydronaphthylamine 272 257, 130 7 7
C2- Tetrahydronaphthylamine 286 271, 159 7 10
C3- Tetrahydronaphthylamine 300 258, 173, 157 5 5
Aminoindane 244 117 5 4
C1- Aminoindane 258 244, 131 1 2
Aminoquinoline 255 128 2 2
C1- Aminoquinoline 269 142 4 3
C2- Aminoquinoline 283 156, 141 3 0
Aminopyridine 205 78 2 0
Aminothiophene 210 83 1 1
C1- Aminothiophene 224 97, 81 1 2
Aminoacetophenone 246 231, 203, 76 3 3
Aminophenol 220 93 2 1
C1- Aminophenol 234 107, 89 3 2
C2- Aminophenol 248 220, 93 1 1
C3- Aminophenol 262 247, 135 0 3
Aniline 204 77 1 1
C1- Aniline 218 91 2 2
C2- Aniline 232 217, 105 7 5
C3- Aniline 246 119 12 10
C4- Aniline 260 245, 118 17 16
Chloroaniline 238 111 2 3
C1- Chloroaniline 252 125 2 2
C2- Chloroaniline 266 231, 139 6 4
C3- Chloroaniline 280 265, 138 5 3
C4- Chloroaniline 294 279, 152 2 1
Dichloroaniline 272 145 2 2
Bromoaniline 282 155 3 2
Methoxyaniline 234 219, 92 1 1
C3- Methoxyaniline 276 261, 134 2 2
Chloromethoxyaniline 268 253, 126 1 2
Thioaniline 236 109 1 3
C1- Thioaniline 250 123, 108 1 1
Naphthylamine 254 127 2 2
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qMS. The analyses were carried out in full-scan mode so that all
extractable and GC-suitable compounds were detected.
Figure 4a and b show the total ion chromatogram (TIC) of the
aromatic iodine compounds that are proposed to be present in
the urine of non-smoking and smoking donors, respectively. In
both Fig. 4a and b, not all the compounds can be visualized
because of low intensity, especially in the urine of a non-smoker,
but their identification is possible. The mass spectra of all
derivatives showed the typical iodine fragment ion signal with
127m/z; as a consequence, aromatic amines present in the
samples could be identified by monitoring the iodine fragment
ion. Since intensity of the mass fragment 127 is typically small,
it would be beneficial to monitor instead the neutral loss of
iodine. However, so far there is no opportunity in GCxGC
software to do so. For each compound, the isomers (viz. blobs)
were counted to obtain the total sum of analytes present in the
sample. This is summarized in Table 3 with the names of the
anilines and the fragment ions of the iodinated derivatives. In the
urine of a donor exposed to cigarette smoke, ca. 150 aromatic
amines were tentatively identified. Among the substances
found, less than 10 are described in literature in relation with
tobacco smoking–bladder cancer [2, 4, 8]. In the urine of a
person without known exposure to cigarette smoke, many ani-
lines (ca. 120) were still identified; nonetheless, regarding the
number and peak intensities of occurring iodinated derivatives,
the sample was less burdened. Amongst the detected com-
pounds, alkylated anilines were the largest group (n=39), as
shown in Fig. 5a in groups of isomeric homologues (C1- to C4-
anilines). Here, the number of isomers rapidly increases with
larger or more numerous alkyl substituents and the intensities
vary substantially among the isomers. In addition, compounds
of the same nominal mass, such as aminoacetophenone (m/z
246) and C3-anilines (m/z 246), derivatives may elute at similar
retention time in the first dimension but as in this case could be
well separated in the second dimension.
Here, the aminoacetophenone derivat ive (viz.
iodoacetophenone, m/z 246) loses at first a methyl group
(fragment ion m/z 231) followed by a carbonyl group (fragment
ion m/z 203) and an iodo group (fragment ion m/z 76). In the
case of the C3-aniline derivative (m/z 246) an iodo group is lost
(fragment ion m/z 119) followed probably by an ethyl group
(fragment ionm/z 91) and amethyl group (fragment ionm/z 77).
Separation of compounds with the same nominal mass such as
these is not possible when measuring with a conventional GC-
MS with unit mass resolution; hence, this result underlines the
importance of GCxGC-MS for the separation of multiple com-
poundmixtures in complexmatrices. Due to the large number of
compounds and the GCxGC data files, which have much bigger
size compared with conventional GC, analysis and handling of
data, especially for quantitative analysis, is still a great challenge.
In that regard, further progress has been described by Tranchida
et al. [18].We, therefore, suggest the use of a fingerprint analysis
to easily monitor the exposure to aromatic amines providing a
better understanding about their role on the formation of bladder
cancer.
Conclusions
An analytical method was developed to reveal a more com-
plete picture of the occurrence of aromatic amines in urine by
investigation of smoking and non-smoking persons. This
method was at first developed for the detection of aromatic
amines and not for quantification. More aromatic amines
based on peak intensities at higher concentration were identi-
fied in the urine sample of a smoker compared with the urine
of a non-smoker. Since many more aromatic amines occur in
urine of a person exposed to cigarette smoke than hitherto
known, it seems that the health risk potential by these com-
pounds might exceed by far previous expectations. The use of
GCxGC-MS to detect aromatic amines in urine samples was
important for the identification of many structurally related
compounds. The method is very efficient with high sensitivity
Table 3 (continued)





urine of a smoker
Isomers found in
urine of non-smoker
C1- Naphthylamine 268 141 4 4
C2- Naphthylamine 282 155 2 2
C1- Aminobiphenyl 294 279, 152 1 1
C2- Aminobiphenyl 308 181, 166 3 4
Diaminobiphenyl 406 279, 152 1 0
Methylenedianiline 420 293, 166 1 0
C1- Diaminonaphthalene 394 267, 140 3 1
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c
Fig. 5 (a) Reconstructed ion chromatogram (RIC) of a urine sample of a
smoker showing typical m/z associated with homologous alkylated aro-
matic iodine compounds and a separation of aminoacetophenone and C3-
aniline derivatives with the same mass-to-charge ratio, m/z 246. The
compounds selected are derivatives of C1-anilines (m/z 218), C2-
anilines (m/z 232), C3-anilines/aminoacetophenone (m/z 246), and C4-
anilines (m/z 260), and the RIC is generated by summing up signals at
these four m/z; (b) and (c) show mass spectra of iodinated derivatives of
aminoacetophenone and C3-aniline, respectively, with fragmentation pat-
terns and loss of m/z 127 (iodine)
250 X. Lamani et al.
such that single ion monitoring is not required, allowing
recording of full-scan mass spectra for compound identifica-
tion. In the future, quantification of aromatic amines in urine
based on the presented method will be evaluated as well as the
analysis of these compounds in the urine of patients who are
diagnosed with bladder cancer. This eventually may be bene-
ficial for further investigations of biomarkers, which could be
used in the future to diagnose the level of cancer-causing
aromatic amines in urine samples.
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